drugset / Trial / NCT00348712
Efficacy and Safety of Inhaled Pre-prandial Human Insulin in Type 2 Diabetes
RandomizedParallel-groupOpen-labelTreatment
Summary
This trial is conducted in Europe. The aim of this research study is to compare the efficacy of adding inhaled preprandial insulin to metformin compared to adding rosiglitazone to metformin for the treatment of type 2 diabetes and to verify its safety (hypoglycaemia, pulmonary function, body weight, insulin antibodies and side effects).
Timeline
- Start
- 2006-10-30
- Primary completion
- 2008-03-05
- Completion
- 2008-03-05
Outcome
Outcome not reported
Stopped: “See termination reason in detailed description”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Rosiglitazone | Small molecule | 4 mg | Oral |
| Comparator | human insulin | Protein / enzyme biologic | — | Inhaled |
| Comparator | Metformin | Small molecule | 2000 mg | Oral |